dreamcatcher
- 08 Nov 2014 16:51

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to approximately 50 countries internationally.
Based in the UK, the brand was launched in 2005 by Charles Rolls and Tim Warrillow to provide high quality, natural mixers which could accompany the growing demand for premium spirits. The Group now sells a range of 12 differentiated flavours to hotels, restaurants, bars and cafes ("On Trade") as well as supermarkets and off-licenses for retail purchase ("Off Trade"). Approximately 70 per cent. of the Group's sales were derived from outside of the UK in FY13 with the key overseas markets being the US, Spain, and Belgium.
The Group's mixers are designed to be accompaniments for alcoholic spirits or used in cocktails, although they can also be consumed on their own. Since 2005, the Company has launched at least one new product a year, which includes 4 variants of tonic water, 2 variants of ginger beer, 3 variants of lemonade, and one variant each of ginger ale, soda water and cola.
7 November 2014
Admission to AIM and first day of dealings
http://www.fever-tree.com/


dreamcatcher
- 27 Nov 2018 21:00
- 663 of 711
A good time to be taken over.
cynic
- 28 Nov 2018 08:18
- 664 of 711
it did cross my mind that DGE was shorting with a view for a bid
be aware that DGE has been strong for several weeks
skinny
- 30 Nov 2018 11:13
- 665 of 711
cynic
- 30 Nov 2018 12:02
- 666 of 711
many thanks for that
an interesting read
dreamcatcher
- 30 Nov 2018 14:39
- 667 of 711
Are you in UAE cynic? :-))
dreamcatcher
- 30 Nov 2018 16:47
- 668 of 711
Blue-chip analysts tell investors to plough into Fevertree after recent sell-off
Share
13:11 30 Nov 2018
Jefferies still has its uber-bullish 4,300p price target in place, despite a sell-off, which has seen shares almost halve over the past three months
Fevertree’s rapid growth in its home UK market is beginning to normalise
Fevertree Drinks PLC (LON:FEVR) shares perked up on Friday after analysts at two major investment banks published bullish research notes, soothing investors who have had to nurse chunky losses in recent weeks.
The posh tonic maker was noticeably silent in November, a month when investors have become used to seeing a trading update telling them that full-year results will be well ahead of forecasts.
READ: Deutsche Bank expects Fevertree to lose its fizz in coming years
That, coupled with the wider equities sell-off, which has rocked stock markets of late, has seen Fevertree shares plunge from almost 4,000p in September to 2,400p now, wiping out all of 2018’s gains.
Morgan Stanley analyst Richard Felton reckons there is “still plenty of scope” for results to come in ahead of forecasts though.
Jefferies’ Ed Mundy also remains a fan and thinks the recent slump “offers an entry point into one of the most attractive growth stories in European beverages”, noting that management’s tone remains “confident”.
According to data from consumer insights group Nielsen, Fevertree’s growth has been slowing in recent months, although given the rapid growth seen over the past few years, Munday says a normalisation of growth “was always expected”.
His calculations suggest sales of Fevertree Drinks in the UK – which accounts for half of all revenue – could grow by up to 40-50% in the second half of this year.
The US will take over the reins as the AIM company’s growth driver over the next year or two and Mundy highlights the “good conditions” currently in place across the pond for Fevertree to enjoy a successful Stateside expansion.
The analyst repeated his blockbuster 4,300p price target and ‘buy’ recommendation.
Fevertree shares added 2.4% in early afternoon trading to 2,397p, still some way off September’s highs.
cynic
- 01 Dec 2018 07:39
- 669 of 711
yes - a couple of fun-filled days ahead in ksa
dreamcatcher
- 01 Dec 2018 08:53
- 670 of 711
:-))
skinny
- 02 Dec 2018 11:48
- 671 of 711
cynic
- 06 Dec 2018 10:39
- 672 of 711
hey you tosspot ....... i'm told you think 3i on advfn is me ....... he ain't! :-)
iturama
- 06 Dec 2018 11:35
- 673 of 711
Which tosspot are you referring to C? I seem to remember you saying 3i was goldfinger.
ps. what is a tosspot? Maybe I should delete that question before the obvious reply.
cynic
- 06 Dec 2018 11:53
- 674 of 711
3i was certainly GF on here
Fred1new
- 06 Dec 2018 12:24
- 675 of 711
Can we swop Cynic for GF?
2517GEORGE
- 06 Dec 2018 12:32
- 676 of 711
Sorry, as you are a Remainer cynic stays.
Stan
- 06 Dec 2018 13:39
- 677 of 711
Never mind Swap Fred..how about flushing him down the loo )-:
dreamcatcher
- 07 Dec 2018 07:08
- 678 of 711
Director/PDMR Shareholding
RNS
RNS Number : 7881J
Fevertree Drinks PLC
07 December 2018
7 December 2018
Fevertree Drinks plc
("Fever-Tree" or the "Company")
Director/PDMR Shareholding
Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that on 6 December 2018, Jeff Popkin, Non-Executive Director of the Company, purchased, in aggregate, 2,933 ordinary shares in the Company at a volume weighted average price of US $29.54 per ordinary share via US OTC Markets.
dreamcatcher
- 13 Dec 2018 14:11
- 679 of 711
11:20 13/12/2018
Broker Forecast - Deutsche Bank issues a broker note on Fevertree Drinks Plc
Deutsche Bank today reaffirms its hold investment rating on Fevertree Drinks Plc (LON:FEVR) and cut its price target to 2600p (from 3000p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk
dreamcatcher
- 29 Dec 2018 08:48
- 680 of 711
A speculative share tip for 2019 - interactive investor -
Fevertree (FEVR)
Share price 2,483p; p/e ratio 42.7; dividend yield 0.6%
Fevertree Drinks premium drinks mixers generated £104 million of first-half revenue, up 45%, and a 36% increase in pre-tax profit to £32.6 million. The company regularly exceeds expectations, and said in July it would do so again this year. Despite skipping the usual update in November, industry data implies full-year UK growth could be 35-45%, double some estimates. The shares aren't cheap despite their recent slump, and they are volatile, but further progress here and promise of overseas growth make Fevertree a speculative buy.
skinny
- 03 Jan 2019 14:40
- 681 of 711
Financial Calendar
31 JANUARY 2019 - TRADING UPDATE
26 MARCH 2019 - PRELIMINARY RESULTS FOR THE YEAR ENDING 31 DECEMBER 2018
skinny
- 09 Jan 2019 09:36
- 682 of 711
@£25 - an 'interesting' level chart wise.